FDA Import Refusal AEK-9894253-3/10003/1 — SHILPEX PHARMACEUTICALS
The FDA refused shipment AEK-9894253-3/10003/1 from SHILPEX PHARMACEUTICALS (India) on Oct 8, 2026. The refused product falls under Drugs and Biologics — SITAGLIPTIN PHOSPHATE (ANTI-DIABETIC). Cited charge: 75 This firm has 1 other import refusal on record.
Refusal Details
- Date
- Oct 8, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PCY68 SITAGLIPTIN PHOSPHATE (ANTI-DIABETIC)
- Charges
- 75